Ferdinand Molnár
Citata da
Citata da
The human peroxisome proliferator-activated receptor δ gene is a primary target of 1α, 25-dihydroxyvitamin D3 and its nuclear receptor
TW Dunlop, S Väisänen, C Frank, F Molnar, L Sinkkonen, C Carlberg
Journal of molecular biology 349 (2), 248-260, 2005
25-Hydroxyvitamin D3 is an agonistic vitamin D receptor ligand
YR Lou, F Molnár, M Peräkylä, S Qiao, AV Kalueff, R St-Arnaud, ...
The Journal of steroid biochemistry and molecular biology 118 (3), 162-170, 2010
Current status of vitamin D signaling and its therapeutic applications
C Carlberg, F Molnár
Current topics in medicinal chemistry 12 (6), 528-547, 2012
Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators
F Molnár, M Matilainen, C Carlberg
Journal of Biological Chemistry 280 (28), 26543-26556, 2005
1α, 25 (OH) 2-3-epi-vitamin D 3, a natural physiological metabolite of vitamin D 3: its synthesis, biological activity and crystal structure with its receptor
F Molnár, R Sigüeiro, Y Sato, C Araujo, I Schuster, P Antony, J Peluso, ...
PloS one 6 (3), e18124, 2011
Mechanisms of gene regulation
C Carlberg, F Molnár
Springer, 2014
Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket
F Molnár, M Peräkylä, C Carlberg
Journal of Biological Chemistry 281 (15), 10516-10526, 2006
2.1. Structural considerations of vitamin D signaling
F Molnár
Integrative Physiology 5, 191, 2014
Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands
C Carlberg, F Molnár
Current topics in medicinal chemistry 6 (12), 1243-1253, 2006
An update on the constitutive androstane receptor (CAR)
F Molnár, J Küblbeck, J Jyrkkärinne, V Prantner, P Honkakoski
Drug Metabolism and Personalized Therapy 28 (2), 79-93, 2013
Vitamin D receptor ligands: the impact of crystal structures
C Carlberg, F Molnár, A Mourino
Expert opinion on therapeutic patents 22 (4), 417-435, 2012
Antagonist-and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein
H Lempiäinen, F Molnár, M Macias Gonzalez, M Peräkylä, ...
Molecular Endocrinology 19 (9), 2258-2272, 2005
Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view
C Carlberg, F Molnár
Canadian journal of physiology and pharmacology 93 (5), 311-318, 2015
New in Vitro Tools to Study Human Constitutive Androstane Receptor (CAR) Biology: Discovery and Comparison of Human CAR Inverse Agonists
J Küblbeck, J Jyrkkärinne, F Molnár, T Kuningas, J Patel, ...
Molecular pharmaceutics 8 (6), 2424-2433, 2011
Use of comprehensive screening methods to detect selective human CAR activators
J Küblbeck, T Laitinen, J Jyrkkärinne, T Rousu, A Tolonen, T Abel, ...
Biochemical pharmacology 82 (12), 1994-2007, 2011
A structural basis for the species-specific antagonism of 26, 23-lactones on vitamin D signaling
M Peräkylä, F Molnár, C Carlberg
Chemistry & biology 11 (8), 1147-1156, 2004
Vitamin D receptor 2016: novel ligands and structural insights
MA Maestro, F Molnár, A Mourińo, C Carlberg
Expert opinion on therapeutic patents 26 (11), 1291-1306, 2016
A vitamin D receptor selectively activated by gemini analogs reveals ligand dependent and independent effects
T Huet, G Laverny, F Ciesielski, F Molnár, TG Ramamoorthy, ...
Cell reports 10 (4), 516-526, 2015
Structural aspects of Vitamin D endocrinology
N Rochel, F Molnár
Molecular and cellular endocrinology 453, 22-35, 2017
Effects of cooling rate in microscale and pilot scale freeze-drying–Variations in excipient polymorphs and protein secondary structure
BH Peters, L Staels, J Rantanen, F Molnár, T De Beer, VP Lehto, ...
European Journal of Pharmaceutical Sciences 95, 72-81, 2016
Il sistema al momento non puň eseguire l'operazione. Riprova piů tardi.
Articoli 1–20